Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple...
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
About this item
Full title
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Blood cancer journal (New York), 2024-09, Vol.14 (1), p.152-5, Article 152
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Alternative Titles
Full title
Phase II trial of elotuzumab with pomalidomide and dexamethasone for daratumumab-refractory multiple myeloma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_91c6bdbb2c0244cbb8d319fe7979abc9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_91c6bdbb2c0244cbb8d319fe7979abc9
Other Identifiers
ISSN
2044-5385
E-ISSN
2044-5385
DOI
10.1038/s41408-024-01134-3
